Diagnamed Holdings Corp.
DGNMF
$0.032
$0.0182131.88%
| Weiss Ratings | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 131.88% | |||
| 30-Day Total Return | 1.27% | |||
| 60-Day Total Return | 151.97% | |||
| 90-Day Total Return | 451.72% | |||
| Year to Date Total Return | 151.97% | |||
| 1-Year Total Return | -21.18% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -6.43% | |||
| 52-Week Low % Change | 451.72% | |||
| Price | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.03 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Sep 12, 2024 | |||
| 52-Week High Price (Date) | Apr 26, 2024 | |||
| Valuation | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.69M | |||
| Enterprise Value | 1.62M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -25.30% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -12.80 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -3.50 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 80.76M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 800 2684 | |||
| Address | 82 Richmond Street East Toronto, ON M5C 1P1 | |||
| Website | www.diagnamed.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -108.16% | |||
| Return on Equity | -- | |||
| Income Statement | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -459.20K | |||
| Net Income (TTM) | -492.80K | |||
| Net Income Avl. to Common (TTM) | -492.80K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -426.62% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -400.00% | |||
| Balance Sheet | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 79.50K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 113.90K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -203.40K | |||
| Current Ratio (Q) | 0.359 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 113.90K | |||
| Total Current Liabilities (Q) | 317.30K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 317.30K | |||
| Total Common Equity (Q) | -203.40K | |||
| Cash Flow | DGNMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -256.60K | |||
| Levered Free Cash Flow (TTM) | -99.20K | |||
| Cash from Operations (TTM) | -256.60K | |||
